Helix Collaborates With GSK To Provide Access To Its Phenotyped GenoSphere Cohorts

Benzinga · 5d ago

Helix, the leading enterprise genomics company, today announced a multi-year strategic collaboration with GSK, the global biopharma company. This agreement provides GSK access to Helix's continuously growing, deeply phenotyped GenoSphere™ cohorts that cover a wide range of disease areas.

Helix GenoSphere™ cohorts consist of comprehensive Exome+® genomic and rich longitudinal clinical data, enhanced with third party medical, pharmacy, and mortality claims. Designed to accelerate Life Sciences research across the development cycle, these datasets are powered by Helix Research Network®, the largest and fastest growing precision health network in the world.